PTC Therapeutics, Inc. Public Float
PTC Therapeutics, Inc. (PTCT) had Public Float of $3.35 million as of 2025-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-19
- 2025-06-30: Entity Public Float $3.35M.
- 2024-06-28: Entity Public Float $1.73B.
- 2023-06-30: Entity Public Float $2.33B.
- 2022-06-30: Entity Public Float $2.13B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.35M 10-K · filed 2026-02-19 |
| 2024-06-28 | $1.73B 10-K · filed 2025-02-27 |
| 2023-06-30 | $2.33B 10-K · filed 2024-02-29 |
| 2022-06-30 | $2.13B 10-K/A · filed 2023-03-08 |
| 2021-06-30 | $2.19B 10-K · filed 2022-02-22 |
| 2020-06-30 | $2.92B 10-K · filed 2021-02-25 |
| 2019-06-28 | $2.57B 10-K · filed 2020-03-02 |
| 2018-06-30 | $1.52B 10-K · filed 2019-03-01 |
| 2017-06-30 | $682.13M 10-K · filed 2018-03-06 |
| 2016-06-30 | $230.57M 10-K · filed 2017-03-16 |
| 2015-06-30 | $1.35B 10-K · filed 2016-02-29 |
| 2014-06-30 | $683.51M 10-K · filed 2015-03-02 |
| 2013-06-28 | $260.28M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |